Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations
Keyword(s):
2013 ◽
Vol 43
(4)
◽
pp. 1045-1051
◽
Keyword(s):
2006 ◽
Vol 95
(8)
◽
pp. 1070-1075
◽
Keyword(s):
2015 ◽
Vol 12
(1)
◽
pp. 86-90
◽
Keyword(s):
2010 ◽
Vol 78
(3)
◽
pp. S128-S129
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):